Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Effects and Costs of a Day Care Centre Program Designed for People With Dementia (ECOD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01943071
Recruitment Status : Completed
First Posted : September 16, 2013
Last Update Posted : February 10, 2020
The Research Council of Norway
Information provided by (Responsible Party):
Norwegian Centre for Ageing and Health

Brief Summary:
Attending day care centres with programs specifically designed for patients with dementia is believed to postpone admittance to nursing home as well as increase quality of life and well-being for both patients and their family caregivers. We aim to investigate to what degree attendance in day care centres with programs for people with dementia is effective for patient and their caregivers whilst also cost efficient for society. The study consists of a quasi-experimental trial with comparison group. 400 patients with dementia, along with a family caregiver, will be included in the trial. Effects will be measured at baseline, after one and two years. Data collection will be made at three levels; at patient level with measures of cognition, depression, quality of life, functioning in activities in daily living, neuropsychiatric symptoms and death; at caregiver level with measures of depression, level of burden and quality of life; and at societal level with measures of nursing home admittance, hospital stays and use of other health resources. Additionally,a qualitative interview study will include 20 dyads from the main trial. The main focus will be on how attending day care centre programs for patients with dementia affect the lives of both patients and caregivers. Five of these dyads will be followed closely throughout the participation period to be used as case examples.

Condition or disease Intervention/treatment Phase
Dementia Behavioral: Day care for patients with dementia Not Applicable

Detailed Description:
A quasi experimental trial with a comparison group will be performed to evaluate the effect of the day care centre programs by comparing results from municipalities with (intervention group) and without (comparison group) a day care centre program designed for people with dementia using standardized assessment tools. Furthermore, a survey will be used to explore the communication and co-operation between the professional staff at the day care centre, the patients and the family carers by administering questionnaires to all three parties. Only patients with mild degree of dementia will be asked to participate in the questionnaire. Finally, qualitative interviews will be made with 20 dyads of patients and family carers to collect their in depth experience with the day care centre program. Five of these patients and their family carers will be followed closely as case examples for two years.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 261 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Effects and Costs of a Day Care Centre Program Designed for People With Dementia - a 24 Month Controlled Study
Actual Study Start Date : August 1, 2013
Actual Primary Completion Date : December 1, 2017
Actual Study Completion Date : December 31, 2017

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Day care for patients with dementia
Day care for patients with dementia
Behavioral: Day care for patients with dementia
Day care centres designed by the local authorities for patients with dementia

No Intervention: Care as usual
Care as usual

Primary Outcome Measures :
  1. Admittance to nursing home care [ Time Frame: 24 months ]
    The number of patients admitted to nursing home care during a period of 24 months will be the primary outcome for the effect and the cost-consequence analysis

Secondary Outcome Measures :
  1. Change in Quality of life for patients [ Time Frame: 12 and 24 months ]
    The quality of life for patients as measured by Quality of Life - Alzheimer's Disease (QoL-AD)

  2. Change in the patient's functioning of daily living [ Time Frame: 12 and 24 months ]
    The Physical self-Maintenance Scale and Instrumental Activities of Daily Living Scale will be used to assess change in the patient's function of daily living

  3. Change in depressive symptoms in patients [ Time Frame: 12 and 24 months ]
    The change in depressive symptoms will be assessed by Montgomery Asberg Depression Rating Scale (MADRS)by interviews with both patient and family carer and the Cornell Scale for Depression in Dementia (CSDD) by interviews with family carers and a professional caregiver

  4. Change in patient's cognition [ Time Frame: 12 and 24 months ]
    Patient's cognition will be assessed using the Mini Mental State Examination (MMSE) the Clock Drawing Test (CDT), the Trail Making Test A (TMT-A)and the 10 word test of the Consortium to Establish a Registry in Alzheimer's Disease (CERAD)

  5. Change in neuropsychiatric symptoms in patients [ Time Frame: 12 and 24 months ]
    The change in Neuropsychiatric symptoms will be assessed using Neuropsychiatric Inventory Questionnaire (NPI-Q)

  6. Patients death [ Time Frame: 24 months ]
    Number of patients that have died during 24 months will be registered

  7. Change in level of burden in family carers [ Time Frame: 12 and 24 months ]
    Level of burden for family carers will be assessed by using the Relative's Stress Scale (RSS)

  8. Change in family carers depressive symptoms [ Time Frame: 12 and 24 months ]
    The MADRS will be used to assess depressive symptoms in family carers

  9. Change in quality of life for family carers [ Time Frame: 12 and 24 months ]
    QoL-AD will be used to assess quality of life in family carers

  10. Differences in the use of health resources between the intervention group and the control group [ Time Frame: 12 and 24 months ]
    The use of health resources will be measured using the resource Utilization in Dementia scale (RUD)

  11. Differences in quality adjusted life years between the intervention group and the control group [ Time Frame: 12 and 24 months ]
    A generic instrument, the EuroQol (EQ-5D) will be used to measure quality adjusted life years

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age of 65 years or more and living at home
  • Patients in the day care centre group must have attended the centre for at least four weeks and have been there no longer than nine months
  • Dementia of either Alzheimer's type, vascular dementia, dementia with Lewy bodies/Parkinson's disease or a mixture of these types of dementias
  • Capacity to give informed consent as judged by the professional caregivers
  • A Mini Mental Status Examination (MMSE) score of ≥15
  • Having a family carer willing to participate, who see the patients personally at least once a week
  • Attending the day care centre program at least twice a week

Exclusion Criteria:

  • Having applied for nursing home placement
  • Suffering from a serious co-morbid physical disorder with life expectancy less than six months

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01943071

Layout table for location information
Norwegian centre of Ageing and Health
Tønsberg, Norway, 3103
Sponsors and Collaborators
Norwegian Centre for Ageing and Health
The Research Council of Norway
Layout table for investigator information
Study Chair: Knut Engedal, Professor Norwegian Centre for Ageling and health
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Norwegian Centre for Ageing and Health Identifier: NCT01943071    
Other Study ID Numbers: NCAH-ECOD
First Posted: September 16, 2013    Key Record Dates
Last Update Posted: February 10, 2020
Last Verified: February 2020
Keywords provided by Norwegian Centre for Ageing and Health:
day care centre programs
family carers
cost-consequence analysis
Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Mental Disorders